Publications of the KKNMS
Your search in the archive “Publications of the KKNMS” returned the following results:
-
Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic
Von Vural A et al, erschienen in „Front Immunol.“ (Vol. 9, Mai 2018)
-
A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation
Von Voet et al, erschienen in „Nat Commun“ (Vol. 9, Nr. 1, Mai 2018)
-
Immunophenotyping of cerebrospinal fluid cells by Chipcytometry
Von Hümmert MW et al, erschienen in „Journal of Neuroinflammation“ (Vol. 15, Nr. 1, Mai 2018)
-
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Von Jarius S et al, erschienen in „Journal of Neuroinflammation“ (Vol. 15, Nr. 1, Mai 2018)
-
Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters
Von Schwab N et al, erschienen in „Multiple Sclerosis“ (Vol. 24, Nr. 5, April 2018)
-
Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis
Von Stork L et al, erschienen in „JAMA Neurology“ (Vol. 75, Nr. 4, April 2018)
-
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS
Von Fleischer V et al, erschienen in „Mult Scler“ (Vol. 24, Nr. 5, April 2018)
-
Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current treatment strategies?
Von Graetz C et al, erschienen in „Expert Rev Neurother.“ (Vol. 18, Nr. 3, März 2018)
-
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
Von Jarius S et al, erschienen in „Journal of Neuroinflammation“ (Vol. 15, Nr. 1, März 2018)
-
Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients
Von Kalluri SR et al,erschienen in „J Autoimmun.“ (Vol. 88, März 2018)